Transaction #18770 · Form 4 · 0002095250-25-000006
LB PHARMACEUTICALS INC · Stock award · Employee Stock Option (Right to Buy)
LB PHARMACEUTICALS INC · Transacted December 10, 2025 · Filed December 11, 2025
What does this filing report?
An SEC Form 4 filing for LB PHARMACEUTICALS INC records a stock award involving Employee Stock Option (Right to Buy) on December 10, 2025. The reported quantity was 195,000. The filing date is December 11, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- LB PHARMACEUTICALS INC
- Company CIK
- 0001691082
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 195,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 195,000
- Ownership description
- Not reported
- SEC acceptance time
- Dec 11, 2025, 4:15 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Pai Panandiker Kaya Kamlesh ↗
Chief Commercial Officer
CIK 0002095250
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 195,000
- Conversion / exercise price
- 21.36
- Exercise date
- Not reported
- Expiration date
- December 9, 2035
Filing footnotes & remarks
- F1
- One fourth (1/4) of the shares subject to the option award shall vest on November 10, 2026 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments on the last calendar day of each month with the first monthly installment occurring on December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.